Follow the people · Insider

JB

John E. Bishop

Insider · Officer · ARDX

John E. Bishop files insider transactions with the SEC as an officer of Ardelyx (ARDX). We hold 3 disclosed purchases and sales filed since 22 February 2006, 1 of them in the last 90 days.

  • Files forARDX
  • Disclosed buys and sells3 in all, 1 in the last 90 days
  • Last disclosure25 August 2026

Positions held

4 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 23 January 202621 August 2026Officer · Ardelyx (ARDX)13 Form 4 lines · source: SEC Form 4
  • Filed 27 February 202330 January 2024Chief Technology Officer · Lyra Therapeutics (LYRA)2 Form 4 lines · source: SEC Form 4
  • Filed 14 June 202114 October 2022SVP, Chief Technology Officer · Forma Therapeutics Holdings (FMTX)7 Form 4 lines · source: SEC Form 4
  • Filed 17 February 200619 May 2016Senior VP, Pharmaceutical Scie · Momenta Pharmaceuticals (MNTA)269 Form 4 lines · source: SEC Form 4

Everything they disclosed

120 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.